Evidence Library

Showing 10 of 185 results.
Corey Davis, JD, MSPH •
University of North Carolina at Chapel Hill

This study, published in the American Journal of Public Health, collected and characterized all statutes and regulations effective from 1998 through 2011 governing the operation of prescription monitoring programs. As of 2011, 10 states required PMPs to report suspicious activity to law enforcement, while only three required reporting to the patient’s physician. None required linkage to drug treatment or required all prescribers to review PMP data before prescribing. Few explicitly address data retention.

 
Fernando Wilson, PhD •
University of Nebraska Medical Center

Illegal drug use is a persistent problem, prescription drug abuse is on the rise, and there is clinical evidence that drug use reduces driving performance. This study describes trends in characteristics of drivers involved in fatal motor vehicle crashes who test positive for drugs, and finds that the profile of a drugged driver has changed substantially over time. An increasing share of these drivers is now testing positive for prescription drugs, cannabis, and multiple drugs.

 
Alexander Wagenaar, PhD •
Emory University
Frank Chaloupka, PhD •
University of Illinois at Chicago, PHLR Methods Core
Beau Kilmer, PhD •
RAND
Rosalie Pacula, PhD •
RAND

This study offers lessons learned from alcohol and tobacco regulation. The researchers recommend that if states decide to experiment with marijuana policy, they should prevent retail price drops, limit marketing, and work hard to measure and prevent impaired driving. They also note the importance of adopting a state monopoly, restricting and monitoring licenses for use and distribution, restricting public consumption, and limiting the types of products sold.

 
In their Critical Opportunities presentation, Ryan Cramer and Lauren Slive suggest strengthening the HIPAA Privacy Rule by adopting the Health Information Technology and Economic and Clinical Health (HITECH) Act. The HITECH provision allows patients to demand that confidentiality be maintained when services are paid for in full out-of-pocket.
 

Congenital heart defects cause nearly one-quarter of deaths due to birth defects in infants. Nearly 5,000 babies are born each year with seven specific Critical Congenital Heart Defects or Critical Congenital Heart Disease (CCHD). There is a low-cost, non-invasive screening procedure, called pulse oximetry, that is effective in detecting CCHD. By making this screening mandatory, CCHD could be detected early and follow-ups could be done to improve health.

 

Pages